| Nathan H. Fowler, M.D. |
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Office Address
The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Boulevard
Unit Number: Unit 429
Houston, TX 77030
Room Number: FC6.3064
Phone: 713-792-2860
Fax: 713-794-5656
Email: nfowler@mdanderson.org
1515 Holcombe Boulevard
Unit Number: Unit 429
Houston, TX 77030
Room Number: FC6.3064
Phone: 713-792-2860
Fax: 713-794-5656
Email: nfowler@mdanderson.org
Education & Training
Degree-Granting Education | |
| 2001 | University of Texas Medical Branch, Galveston, TX, MD, Medicine |
| 1997 | University of Houston, Houston, TX, BS, Biology |
Postgraduate Training | |
| 7/2006-6/2007 | Chief Fellow, Georgetown University, Washington, DC |
| 7/2004-8/2007 | Clinical Fellowship, Hematology/Oncology, Georgetown University, Washington, DC |
| 7/2002-6/2004 | Clinical Residency, University of Texas Medical Branch, Galveston, TX |
| 7/2001-6/2002 | Clinical Internship, University of Texas Medical Branch, Galveston, TX |
Board Certifications
| 8/2008 | Medical Oncology |
| 8/2004 | American Board of Internal Medicine |
Experience/Service
Military or Other Governmental Service
Nuclear, Biological and Chemical Defense Specialist, US Army, 1988-1991
Honors and Awards
| 2006-2007 | Georgetown Chief Fellow |
| 1996 | Natural Science and Mathematics Scholar and Fellow |
| 1995-1996 | Order of Omega Greek Honor Society |
| 1994-1996 | Dean's List |
| 1991 | National Defense Medal, US Army |
| 1991 | Overseas Service Ribbon, US Army |
| 1990 | Army Achievement Medal, US Army |
| 1990 | Valedictorian. Nuclear, Biological, and Chemical Defense School, US Army |
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Goldman L, Ezzat S, Mokhtar N, Abdel-Hamid A, Fowler N, Gouda I, Eissa S, Abdel-Hamid M, Loffredo C. Viral and non-viral risk factors for non-Hodgkin's Lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20(6):981-7, 8/2009. e-Pub 3/2009. PMID: 19263231. |
| 2. | Fowler N, Younes A. There will be blood: targeting tumor vasculature. Blood 113(10):2121-2122, 3/2009. PMID: 19264922. |
| 3. | Fowler N, Spell D. Case Report. Parotid Gland Metastasis as the Initial Manifestation of a Non-Small Cell Lung Cancer. Southern Medical J. Vol 95:S:25, 2002. |
Abstracts | |
| 1. | Cataldo V, Thompson M, Toth B, Sanjoro P, Bekele N, Jimenez C, Murphy W, Huen A, Arbuckle R, Fanale M, Fayad L, Fowler N, Kwak L, McLaughlin P, Neelapu S, Pro B, Rodriguez A, Shah J, and Hagemeister F. Bone Loss in Patients with Previously Untreated Lymphoma: The Effect of Periodontal Disease on the Use of Zoledronic Acid. Blood (ASH Annual Meeting Abstracts) 112:5297, 11/2008. |
| 2. | McLaughlin P, Neelapu S, Fanale M, Rodriguez M, Ayala A, Pro B, Hagemeister F, Younes A, Neel S, Fowler N, Hess M, and Kwak L. R-FND Followed by Radioimmunotherapy for High-Risk Follicular Lymphoma. Blood (ASH Annual Meeting Abstracts) 112:3056, 11/2008. |
| 3. | S.A. Siddique, N. Fowler, E. Asatiani, B. Mavromatis, P. Cohen, C.M. Kessler and B.D. Cheson. Infectious complications associated with alemtuzumab treatment. Journal of Clinical Oncology 25(18S) (#13504), 6/2007. |
Last updated: 8/28/2009
- Global Navigation
- About Us
- Locations
- Events
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient & Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children’s Cancer Hospital
- Services & Amenities
- Physician Directory
- Education and Research
- Departments, Programs & Labs
- PeopleFinder
- Research at M.D Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alerts
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
© 2009 The University of Texas M. D. Anderson Cancer Center

